Cardinal Health Stock (NYSE:CAH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$110.35

52W Range

$89.00 - $116.05

50D Avg

$107.92

200D Avg

$104.65

Market Cap

$27.09B

Avg Vol (3M)

$1.93M

Beta

0.61

Div Yield

$2.02 (1.80%)

CAH Company Profile


Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Show More

Industry

Medical - Distribution

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

47,922

IPO Date

Aug 04, 1983

Website

CAH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 23Jun 18
Medical Member$15.01B$15.58B
Pharmaceutical Member-$121.24B

Fiscal year ends in Jun 23 | Currency in USD

CAH Financial Summary


Jun 23Jun 22Jun 21
Revenue$205.01B$181.36B$162.47B
Operating Income$727.00M$1.65B$1.84B
Net Income$261.00M$-932.00M$611.00M
EBITDA$2.47B$2.34B$2.62B
Basic EPS$1.00$-3.34$2.09
Diluted EPS$1.00$-3.34$2.08

Fiscal year ends in Jun 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Aug 14, 24 | 1:10 PM
Q3 24May 02, 24 | 12:17 PM
Q2 24Feb 01, 24 | 11:32 AM

Peer Comparison


TickerCompany
ABCCencora
MCKMcKesson Corporation
OMIOwens & Minor, Inc.
EDAPEDAP TMS S.A.
PDCOPatterson Companies, Inc.
ZYXIZynex, Inc.
HSICHenry Schein, Inc.